Based on a review of available literature, this monograph explores the links between poverty and noncommunicable diseases (NCDs) with particular reference to the Western Pacific Region. The project was specifically designed to stimulate discussion on the relationship between poverty and NCDs, to contribute to the reduction of the impact of NCDs in developing countries, and to foster an understanding of how to improve health outcomes for the poor or socially marginalized groups with NCDs.
The WHO European Region has faced high rates of external and internal migration in recent years, with concerns that this is contributing to the burden of tuberculosis (TB), multidrug-resistant TB (MDR-TB) and TB/HIV coinfection in some countries. This report examines evidence of effective and efficient service packages for the prevention, diagnosis and treatment of TB to inform strategies to address the TB burden in refugee and migrant populations. Significant regional variations were identified in both migration levels and TB burden in refugees and migrants, as well as in approaches to TB control, with low quality of evidence in many cases. While it is unlikely that a single strategy/package will be effective for all situations, the evidence highlights some common approaches that could guide policy-making and service development. TB elimination targets for the Region will not be met unless inequalities in access to screening and treatment for migrants are addressed, alongside efforts to tackle TB globally.
The report identified policies and other relevant documents through an evidence review of peer-reviewed and grey literature supplemented by an enquiry of experts in health health literacy and policy in the Region and by health literacy policies included in the most recent peer-reviewed document on health literacy activities published in the Region (European Union (EU) countries only: HEALIT4EU). Further efforts to identify policies from countries of the Commonwealth of Independent States were unfruitful. Based on this evidence synthesis the following policy considerations are proposed: - consider the existing policies and related activities gathered in this review to develop or enhance health literacy policies and related activities to benefit citizens patients and communities; - broaden the range of areas of activity required for holistic health literacy policies to include the lived environment the workplace the media and digital/e-health at all societal levels ? individual community organization and system (legislative); - strengthen the evidence base for health literacy at all societal levels to ensure that policies address needs specific to the national or local context; -incorporate robust qualitative and quantitative evaluations into health literacy policies and interventions ? quantitative methods could include pre- and post-activity health literacy evaluations of evidence of health social and economic effects at all levels; and ?incorporate facilitators of successful implementation such as intersectoral working political leadership and strategies to overcome cultural barriers into health literacy policy. Member States would benefit from adopting such comprehensive frameworks and using metrics to design effective policies that support the development of a health-literate Europe.
The Atlas does more than give national averages for all the main causes of death in the WHO European Region; it gives data on regions within countries and shows changes in mortality at this level between 1980/1981 and 1990/1991. Finally, it literally draws pictures of health in Europe, presenting the data collected in vivid and informative maps and bar charts. By showing differences in mortality from various causes in the European Region, the Atlas also indicates areas in which more study is needed to determine both the reasons for these differences and the most appropriate action to reduce them.
This book, commissioned by the World Health Organization (WHO) and written by international experts, provides consensus views on the most important issues related to allergic hypersensitivities. The text details predictive testing, diagnosis, epidemiological monitoring of intervention measures, sources of sensitizing agents, and mechanisms of action. Contributors extensively cover allergic hypersensitivity reactions of the skin and the respiratory system. They present the current knowledge on hypersensitivity reactions of the gastrointestinal tract and kidneys. Major gaps in existing information about allergic hypersensitivities are highlighted and recommendations for future research are given. Practical methods are provided for establishing preventive programs. Allergic Hypersensitivities Induced by Chemicals offers valuable information to both scientists and public health officials. This is a useful reference for health professionals in their work with allergies, allergens, and allergy sufferers.
Annotation. Despite considerable progress in malaria control over the last 10 years, malaria is still a serious problem, particularly in sub-Saharan Africa where about 90 per cent of clinical cases occur. Malaria, either alone or in combination with other diseases, is estimated to kill between 1.1 and 2.7 million people worldwide each year. This report analyses the effect of health sector reforms on malaria control programmes.
This study seeks to reinforce the understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and of how they affect medical innovation and access to medical technologies. The second edition comprehensively reviews new developments in key areas since the initial launch of the study in 2013.
Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children).
Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children).
The 19th Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicine took place in Geneva, Switzerland, from 8 to 12 April 2013"--P. vii.
In 2010 the WHO Regional Committee for Europe adopted an ambitious five-year vision of better health in the WHO European Region. The WHO Regional Office for Europe and the 53 countries it serves therefore agreed to follow a roadmap with specific milestones to enable the Regional Office to respond to the changing European environment and to further strengthen it as an evidence-based centre of health policy and public health excellence that could better support the Region's diverse Member States. The work and achievements over the last four years required great effort commitment and cooperation from all parties: the Secretariat and Member States that comprise WHO in Europe which in turn is part of one WHO worldwide and all WHO's partners in the Region. Several publications give highlights of the first two years of this journey. This book covers the second two years which include the halfway point of the period covered by the vision. It describes how we are making our vision a reality to secure better health for everyone in Europe.
Social justice is a matter of life and death. It affects the way people live, their consequent chance of illness, and their risk of premature death. We watch in wonder as life expectancy and good health continue to increase in parts of the world and in alarm as they fail to improve in others.
The World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations advises the Director-General of WHO in the area of medicines quality assurance. It provides independent expert recommendations and guidance to ensure that medicines meet standards of quality, safety and efficacy in all WHO Member States. Its advice is developed through a broad consensus-building process and covers all areas of quality assurance of medicines, from their development to their distribution to patients. In the area of quality control, the Expert Committee reviewed new and revised specifications and general texts for inclusion in The International Pharmacopoeia, and received the annual report of the European Directorate for the Quality of Medicines & HealthCare (EDQM), the custodian centre for International Chemical Reference Substances (ICRS). The Committee adopted a number of monographs, general texts and ICRS. It noted the report on Phase 6 of the External Quality Assurance Assessment Scheme (EQAAS) and on new approaches to ensure sustainability of this scheme through user fees. The Committee further acknowledged the progress of good pharmacopoeial practices (GPhP), and adopted the document on GPhP which was prepared by the consecutive international meetings of world pharmacopoeias. In the various quality assurance-related areas the Expert Committee was presented with a number of new and revised guidelines related to good manufacturing practices (GMP), distribution and trade of pharmaceuticals and regulatory practice. It adopted 10 guidelines as listed below as well as 22 new specifications and general texts for inclusion in The International Pharmacopoeia. The Committee took note of ongoing work to promote collaboration and information exchange through the good regulatory practice project and welcomed the development of a comprehensive set of guidelines for all national regulatory authorities through this project.
Development strategies in a number of sectors can have adverse consequences for health and the environment. This report looks in particular at food and agriculture, water, energy, industry, and urbanization, in each case, examining the adverse health effects of various sectoral policies and recommending approaches and action aimed at mitigating or preventing them. The discussion is underpinned by concern for the principles of a more equitable access to resources both within and between countries, and participation of the public in formulating, implementing and evaluating plans and projects... [Editeur]
Overweight and obesity have become urgent global health issues in recent decades. Globally the number of overweight children under the age of 5 years has increased from 32 million in 2000 to 41 million in 2014 corresponding to an increase in prevalence from 5.0% to 6.1%. It is estimated that at the current pace by 2020 some 9% of all children under 5 years will be overweight. Furthermore an increase in adult obesity prevalence has been observed in all countries and globally the prevalence of obesity among adults has doubled from 1980 to 2014 from 5% to 11% for men and from 8% to 15% for women. Overweight and obesity were estimated to account for 3.4 million deaths annually and 93.6 million disability-adjusted life years (DALYs) 1 in 2010. The burden of overweight and obesity is inequitably distributed and affects some population groups and geographical areas more than others based on their social characteristics which are also inequitably distributed. Vulnerability to overweight and obesity might depend on for instance urban or rural residence socioeconomic status ethnicity or the geographical area where people live and their nutritional status in the first 1000 days of life. This report intends to assist policy-makers in the World Health Organization (WHO) Western Pacific Region by contributing to a better understanding of the unequal distribution of overweight and obesity in the Region and by providing policy options to address the social determinants of overweight and obesity. Identifying vulnerable population groups or areas can help policymakers programme managers and other actors to improve programme targeting and increase the effectiveness and improve the health and well-being of the most vulnerable.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.